Clinical Trials Logo

Clinical Trial Summary

Creativity is a complex neuro-psycho-philosophical phenomenon that is difficult to define. Neurocognitive models of creativity suggest that creativity is associated with the activity of a distributed, bilateral fronto-temporal and parietal network. Therefore, a modulation of frontal activity is necessary to allow a certain degree of "controlled disinhibition", which seems to be necessary for creative thinking. In addition, a modulation of the lower parietal lobe (IPL) might allow targeting the brain regions responsible for idea generation. This project will investigate the application of transcranial magnetic stimulation (TMS) with the intent of modulating creativity performance of healthy subjects. Resting state electroencephalography (EEG) that will be acquired pre- and post-TMS and participants' creative performance will be measured. Perspectives include a better understanding of the differences between high- and low-creativity groups, as measured by a creativity test battery, in their response to TMS. Additional perspectives are whether there are differences in creativity performance depending on the stimulation location.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Creativity Performance in Healthy Subjects

NCT number NCT04650438
Study type Interventional
Source Insel Gruppe AG, University Hospital Bern
Contact
Status Withdrawn
Phase N/A
Start date April 2021
Completion date February 2022